RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma

Abstract

Background: Interferon-inducible 16 (IFI16)/caspase-1 inflammasome activates and secretes IL-1β. However, it is still unclear whether the IFI16 inflammasome is involved in human laryngeal squamous cell carcinoma. Autophagy directly removed inflammasome components and limited early IL-1β production. RalB is required for the crosstalk between inflammasome and autophagy in macrophages. Dihydroartemisinin (DHA), the main derived ingredient of artemisinin, has a variety of biological activities. The mechanism of DHA in regulating the crosstalk between IFI16 inflammasome and autophagy by inhibiting RalB expression was analyzed in order to provide clues for new therapeutic methods in laryngeal cancer. Methods: The expression of IFI16 was analyzed by Oncomine and GEPIA databases and detected by Western blot and immunohistochemistry. The relationship between IFI16 inflammasome and autophagy was investigated by transmission electron microscopy, immunofluorescence assay, etc. in Hep-2, Cal-27 and HeLa cells treated with DHA. The xenograft tumor of hep-2 cell in nude mice were used to assess the effect of DHA on laryngeal cancer. Results: It was reported for the first time in this study that IFI16 was overexpressed and positively correlated with caspase-1 in laryngeal carcinoma tissues. DHA significantly inhibited the activation of inflammasome and reduced IL-1β production in the microenvironment of Hep-2 cell xenograft tumor in nude mice. Mechanistically, we found that DHA degraded RalB, inhibited USP33 expression, and triggered autophagy. Meanwhile, enhanced autophagy can reduce the expression of RalB and USP33. Furthermore, DHA promotes autophagy, which suppresses the activation of IFI16/ caspase-1 inflammasome and IL-1β production. Conclusions: Therefore, our findings demonstrate that DHA may act as a RalB inhibitor to regulate the crosstalk between autophagy and IFI16/caspase-1 inflammasome, which inhibits IL-1β production in tumor microenvironment.

Dihydroartemisinin Inhibits TGF-β-Induced Fibrosis in Human Tenon Fibroblasts via Inducing Autophagy

“…It was previously reported that DHA exerted an effect in multiple diseases, including fibrosis. 8 , 26 , 27 In the present study, DHA inhibited the TGF-β-induced fibrosis of HTFs following glaucoma surgery by inducing autophagy. To the best of our knowledge, the present study was the first to determine the function of DHA in the formation of HS.…”

Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases

“…In addition to inducing apoptosis, DHA also has the ability to induce autophagy in tumors (22,41,69,77,81). When DHA damages tumor cells, autophagy is activated to clear damaged organelles, but excessive autophagy often leads to cell death.…”

Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications

“…Activation involves Ca 2+ binding and GFL‐GFR recognition, culminating in homodimerization, autophosphorylation, and downstream signaling activation [66] . This influences multiple pathways, including PI3K/AKT, RAS/RAF/MEK/ERK, JAK2/STAT3, and PLC‐γ, impacting cell proliferation, survival, and differentiation [67] . Aberrations in RET and overexpression are discerned across a wide array of cancers, including breast, pancreatic, colorectal, melanoma, lung, and prostate cancers, contributing to tumor proliferation, invasion, and migration [68] .…”

“…[66] This influences multiple pathways, including PI3K/AKT, RAS/RAF/MEK/ERK, JAK2/STAT3, and PLC-γ, impacting cell proliferation, survival, and differentiation. [67] Aberrations in RET and overexpression are discerned across a wide array of cancers, including breast, pancreatic, colorectal, melanoma, lung, and prostate cancers, contributing to tumor proliferation, invasion, and migration. [68] Tyrosine kinase inhibitors, particularly multikinase inhibitors, emerge as promising strategies targeting RET-driven diseases.…”